Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 27% Over Last Week

Yahoo FinanceJan 8 05:17 ET

Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Price Is Right But Growth Is Lacking After Shares Rocket 32%

Simply Wall StJan 4 07:13 ET

Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why

Zacks Jan 2 11:15 ET

Catalyst Watch: Eyes on Electric Vehicle Deliveries, Retail Data and Housing Reads

Seeking AlphaDec 27, 2024 15:00 ET

Atara Biotherapeutics Analyst Ratings

BenzingaDec 20, 2024 07:59 ET · Ratings

Rodman & Renshaw Initiates Coverage on Atara Biotherapeutics With Buy Rating, $25 Price Target

MT NewswiresDec 20, 2024 07:12 ET · Ratings